Self-management Telehealth Program for Scleroderma
NCT06990386 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72
Last updated 2025-05-30
Summary
Scleroderma causes the skin on the hands to harden, causing the hands to contract, and the fingers to bend abnormally, which affect the patient's work and quality of life.
This project aims to test the effect of a self-management telehealth program. The goal of this clinical trial is to improving hand strength and function in SSc patients.
Participants will: randomly into 3 groups; a) usual education, b) watching 3.27-minute video guide as needed adding on usual education, c) watching video guide and weekly telephone notifications adding to usual education.
A physical therapist coached home program for self-hand and joint exercise, a nursing coach home routine hand care.
Visit the clinic with a diary at 6 weeks after program for checkups and tests
Researchers will compare hand strength and function, self-management behavior, HAMIS scores, hand grip strength (HGS), and quality of life (QoL) between groups, as well as the changes in these parameters at week 6 compared to baseline.
Conditions
- Scleroderma
Interventions
- BEHAVIORAL
-
self-management program
Self-management booklet based on the self-management framework consisting of 4 categories: a) self-monitoring, which consisted of self-observation and self-recording of DU and RP; b) performing special tasks to manage the disease, including keeping warm, maintaining moisture, and taking traumatic wound precautions; c) information seeking; and d) self-adjustment based on disease activity and treatment.
- BEHAVIORAL
-
Video guide and usual education
Video guide was the hand and joint exercise video guide that included a 3.27-minute educational video on 6 basic daily hand exercises including: a) stretching wrist flexion and extension, b) range of motion (ROM) ulnar and radial deviation, c) ROM finger abduction and adduction, d) finger pincer, e) finger flexion and extension, and f) finger grab.
- BEHAVIORAL
-
Telephone notification, video guide and usual education
Telephone notifications consisted of weekly calls for further continuity and engagement with hand exercises. Each call lasted about 10 minutes, providing problem-solving support, knowledge reinforcement, and motivation to encourage adherence to the program.
Sponsors & Collaborators
-
Khon Kaen University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-11
- Primary Completion
- 2024-08-29
- Completion
- 2025-04-30
Countries
- Thailand
Study Locations
More Related Trials
-
Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study
NCT03092024 ·Status: COMPLETED ·Phase: NA
-
Utility of Breath-holding Test in Systemic Sclerosis
NCT04484948 ·Status: COMPLETED ·Phase: NA
-
UVA-1 for Treatment of Skin Tightening and Improvement of Hand Function in Scleroderma
NCT04875078 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Exercise With Scleroderma Functional Outcomes
NCT06425653 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome
NCT02165111 ·Status: COMPLETED ·Phase: PHASE3
-
Online Fatigue Intervention Program for People With Scleroderma
NCT04401943 ·Status: COMPLETED ·Phase: NA
-
Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis
NCT02558543 ·Status: TERMINATED ·Phase: PHASE2
-
The Effects of Exercise in Patients With Systemic Sclerosis
NCT03058887 ·Status: COMPLETED ·Phase: NA
-
Scleroderma Patient-centered Intervention Network (SPIN) Hand Program
NCT03419208 ·Status: COMPLETED ·Phase: NA
-
Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1
NCT06373263 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Finger Hardness Measure in Scleroderma
NCT01111786 ·Status: COMPLETED
-
Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)
NCT02396238 ·Status: COMPLETED ·Phase: NA
-
Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis
NCT00318188 ·Status: COMPLETED ·Phase: NA
-
Making it Work Program for Systemic Sclerosis
NCT06338722 ·Status: COMPLETED ·Phase: NA
-
Pirfenidone as Treatment of Skin Fibrosis in Systemic Sclerosis
NCT03068234 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612 ·Status: COMPLETED ·Phase: NA
-
A Comparison Between Two Educational Methods in the Rehabilitation of the Microstomia in Systemic Sclerosis
NCT03766243 ·Status: COMPLETED ·Phase: NA
-
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
NCT03509064 ·Status: RECRUITING
-
Pragmatic Clinical Trials in Scleroderma
NCT03610217 ·Status: UNKNOWN ·Phase: NA
-
Stress, Scleroderma and Quality of Life
NCT05617066 ·Status: COMPLETED ·Phase: NA
-
BIOLOGICAL EXPLORATION OF THE VASCULAR FRACTION FROM THE ADIPOSE TISSUE OF PATIENTS WITH SCLERODERMIA
NCT03629002 ·Status: UNKNOWN
-
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
NCT02349009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Soluble VE-cadherin and VE-cadherin Antibody in Sclerodermic Sclerosis
NCT02212249 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis
NCT02663895 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Respiratory Muscle Sarcopenia in Patients with Systemic Sclerosis
NCT06598982 ·Status: RECRUITING